Microglia and multiple sclerosis

Journal of Neuroscience Research

Volumn 81, Issue 3, 2005, Pages 363-373

  Jack, Carolyn ^a   Ruffini, Francesca ^a   Bar Or, Amit ^a   Antel, Jack P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antigen presentation; Central nervous system; Nitric oxide; Phagocytosis; Toll like receptors

Indexed keywords

NITRIC OXIDE; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTATION; CELL DEATH; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; FEEDBACK SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANIMALS; ANTIGEN PRESENTATION; CENTRAL NERVOUS SYSTEM; HUMANS; INFLAMMATION; MACROPHAGES; MICROGLIA; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; NITRIC OXIDE;

EID: 25444523444     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20482     Document Type: Review

References (103)

1. Akira S, Hemmi H. 2003. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85:85-95.
2. Akiyama H, McGeer PL. 1990. Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 30:81-93.
3. Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B, Prozorovski T, Sallach S, Endres M, Brocke S, Nitsch R, Zipp F. 2003. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J Exp Med 197:725-733.
4. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, Koprowski H. 1995. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 92:12041-12045.
5. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468.
6. Becher B, Antel JP. 1996. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18:1-10.
7. Becher B, Blain M, Antel JP. 2000. CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J Neuroimmunol 102:44-50.
8. Becher B, Dodelet V, Fedorowicz V, Antel JP. 1996. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest 98:1539-1543.
9. Bechmann I, Peter S, Beyer M, Gimsa U, Nitsch R. 2001. Presence of B7-2 (CD86) and lack of B7-1 (CD80) on myelin phagocytosing MHC-II-positive rat microglia is associated with nondestructive immunity in vivo. FASEB J 15:1086-1088.
10. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW. 2002. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-1029.
11. Blander JM, Medzhitov R. 2004. Regulation of phagosome maturation by signals from toll-like receptors. Science 304:1014-1018.
12. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36:778-786.
13. Broholm H, Andersen B, Wanscher B, Frederiksen JL, Rubin I, Pakkenberg B, Larsson HB, Lauritzen M. 2004. Nitric oxide synthase expression and enzymatic activity in multiple sclerosis. Acta Neurol Scand 109:261-269.
14. Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013-1021.
15. Chan A, Seguin R, Magnus T, Papadimitriou C, Toyka KV, Antel JP, Gold R. 2003. Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta. Glia 43:231-242.
16. Colasanti M, Persichini T, Di Pucchio T, Gremo F, Lauro GM. 1995. Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor alpha stimulation. Neurosci Lett 200:144-146.
17. Cross AH, Manning PT, Keeling RM, Schmidt RE, Misko TP. 1998. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 88:45-56.
18. Davoust N, Jones J, Stahel PF, Ames RS, Barnum SR. 1999. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia 26:201-211.
19. de Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P. 1997. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 56: 10-20.
20. De Simone R, Giampaolo A, Giometto B, Gallo P, Levi G, Peschle C, Aloisi F. 1995. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 54:175-187.
21. Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA. 2000. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest 105: 967-976.
22. Fabrizi C, Silei V, Menegazzi M, Salmona M, Bugiani O, Tagliavini F, Suzuki H, Lauro GM. 2001. The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106-126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase. J Biol Chem 276:25692-25696.
23. Farina C, Then BF, Albrecht H, Meinl E, Yassouridis A, Neuhaus O, Hohlfeld R. 2001. Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells. Brain 124:705-719.
24. Farina C, Wagenpfeil S, Hohlfeld R. 2002. Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis. A pilot study. J Neurol 249:1587-1592.
25. Fearon DT. 1997. Seeking wisdom in innate immunity. Nature 388:323-324.
26. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 154:4309-4321.
27. Gasque P, Singhrao SK, Neal JW, Gotze O, Morgan BP. 1997. Expression of the receptor for complement C5a (CD88) is upregulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol 150:31-41.
28. Gasque P, Singhrao SK, Neal JW, Wang P, Sayah S, Fontaine M, Morgan BP. 1998. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J Immunol 160:3543-3554.
29. Gehrmann J, Banati RB, Kreutzberg GW. 1993. Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules. J Neuroimmunol 48:189-198.
30. Genain CP, Cannella B, Hauser SL, Raine CS. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5:170-175.
31. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551-560.
32. Graeber MB, Streit WJ, Buringer D, Sparks DL, Kreutzberg GW. 1992. Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain. J Neuropathol Exp Neurol 51:303-311.
33. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, SiTahar M. 2002. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 168: 5989-5992.
34. Hill KE, Zollinger LV, Watt HE, Carlson NG, Rose JW. 2004. Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. J Neuroimmunol 151:171-179.
35. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748.
36. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752.
37. Hume DA, Perry VH, Gordon S. 1983. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 97:253-257.
38. Jack C, Kuhlmann T, Antel J. 2004a. Differential susceptibility of human adult oligodendrocytes to injury mediated by nitric oxide and peroxynitrite. Neurology 62(Suppl):117.
39. Jack C, Montgrain V, Ante J. 2004b. Ligation of Toll-like receptors on human adult microglia induces the production of interferon-beta. Clin Invest Med 27:50.22.
40. Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P. 1999. The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy. Clin Exp Allergy 29(Suppl)2:33-36.
41. Karp CL, Boxel-Dezaire AH, Byrnes AA, Nagelkerken L. 2001. Interferon-beta in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10? Curr Opin Neurol 14:361-368.
42. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R. 1999. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865-870.
43. Kim HJ, Ifergan I, Antel JP, Seguin R, Duddy M, Lapierre Y, Jalili F, Bar-Or A. 2004. Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J Immunol 172:7144-7153.
44. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
45. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398-401.
46. Lassmann H. 2003. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 206:187-191.
47. Lassmann H, Zimprich F, Vass K, Hickey WF. 1991. Microglial cells are a component of the perivascular glia limitans. J Neurosci Res 28:236-243.
48. Lee YB, Nagai A, Kim SU. 2002. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 69:94-103.
49. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T. 2002. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22:2478-2486.
50. Ling C, Sandor M, Fabry Z. 2003. In situ processing and distribution of intracerebrally injected OVA in the CNS. J Neuroimmunol 141:90-98.
51. Losy J, Michalowska-Wender G, Wender M. 2002. Interleukin 12 and interleukin 10 are affected differentially by treatment of multiple sclerosis with glatiramer acetate (Copaxone). Folia Neuropathol 40: 173-175.
52. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717.
53. Magnus T, Chan A, Grauer O, Toyka KV, Gold R. 2001. Microglial phagocytosis of apoptotic inflammatory T cells leads to downregulation of microglial immune activation. J Immunol 167:5004-5010.
54. Matzinger P. 2002. The danger model: a renewed sense of self. Science 296:301-305.
55. Medzhitov R, Janeway CA. 2002. Decoding the patterns of self and non-self by the innate immune system. Science 296:298-300.
56. Moore FG, Wolfson C. 2002. Human herpes virus 6 and multiple sclerosis. Acta Neurol Scand 106:63-83.
57. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF 3rd. 2001. The extra domain A of fibronectin activates Toll-like receptor 4 J Biol Chem 276:10229-10233.
58. Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL. 2001. Multiple sclerosis: genomic rewards. J Neuroimmunol 113:171-184.
59. Pender MP. 1999. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance. Immunol Cell Biol 77:216-223.
60. Perry VH, Newman TA, Cunningham C. 2003. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci 4:103-112.
61. Prineas JW, Kwon EE, Cho ES, Sharer LR, Barnett MH, Oleszak EL, Hoffman B, Morgan BP. 2001. Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 50:646-657.
62. Qin Y, Zhang DQ, Prat A, Pouly S, Antel J. 2000. Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients. J Neuroimmunol 108:201-206.
63. Rezaie P, Bohl J, Ulfig N. 2004. Anomalous alterations affecting microglia in the central nervous system of a fetus at 12 weeks of gestation: case report. Acta Neuropathol (Berl) 107:176-180.
64. Rezaie P, Male D. 1999. Colonisation of the developing human brain and spinal cord by microglia: a review. Microsc Res Tech 45:359-382.
65. Rose JW, Hill KE, Watt HE, Carlson NG. 2004. Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion. J Neuroimmunol 149:40-49.
66. Satoh J, Lee YB, Kim SU. 1995. T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res 704:92-96.
67. Schjetne KW, Thompson KM, Nilsen N, Flo TH, Fleckenstein B, Iversen JG, Espevik T, Bogen B. 2003. Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. J Immunol 171:32-36.
68. Schmidt S. 1999. Candidate autoantigens in multiple sclerosis. Mult Scler 5:147-160.
69. Schrijver IA, van Meurs M, Melief MJ, Wim AC, Buljevac D, Ravid R, Hazenberg MP, Laman JD. 2001. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 124: 1544-1554.
70. Scott GS, Virag L, Szabo C, Hooper DC. 2003. Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia 41:105-116.
71. Seguin R, Biernacki K, Prat A, Wosik K, Kim HJ, Blain M, McCrea E, Bar-Or A, Antel JP, 2003a. Differential effects of Th1 and Th2 lymphocyte supernatants on human microglia. Glia 42:36-45.
72. Seguin R, Moditi Z, Rotondo R, Biernacki K, Wosik K, Prat A, Antel JP. 2003b. Human brain endothelial cells supply support for monocyte immunoregulatory functions. J Neuroimmunol 135:96-106.
73. Seong SY, Matzinger P. 2004. Opinion: Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4:469-478.
74. Sorensen TL, Trebst C, Kivisakk P, Klaege KL, Majmudar A, Ravid R, Lassmann H, Olsen DB, Strieter RM, Ransohoff RM, Sellebjerg F. 2002. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J Neuroimmunol 127:59-68.
75. Suzuki N, Suzuki S, Yeh WC. 2002. IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol 23:503-506.
76. Swanborg RH, Whittum-Hudson JA, Hudson AP. 2003. Infectious agents and multiple sclerosis-are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 136:1-8.
77. Talbot PJ, Arnold D, Antel JP. 2001. Virus-induced autoimmune reactions in the CNS. Curr Top Microbiol Immunol 253:247-271.
78. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. 2002. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99-111.
79. Thoma-Uszynski S, Kiertscher SM, Ochoa MT, Bouis DA, Norgard MV, Miyake K, Godowski PJ, Roth MD, Modlin RL. 2000. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 165:3804-3810.
80. Ting JP, Shigekawa BL, Linthicum DS, Weiner LP, Frelinger JA. 1981. Expression and synthesis of murine immune response-associated (Ia) antigens by brain cells. Proc Natl Acad Sci USA 78:3170-3174.
81. Touil T, Deloire-Grassin MS, Vital C, Petty KG, Brochet B. 2001. In vivo damage of CNS myelin and axons induced by peroxynitrite. Neuroreport 12:3637-3644.
82. Trapp BD. 2004. Pathogenesis of multiple sclerosis: the eyes only see what the mind is prepared to comprehend. Ann Neurol 55:455-457.
83. Tsan MF, Gao B. 2004. Endogenous ligands of Toll-like receptors. J Leukoc Biol 76:514-519.
84. Ulvestad E, Williams K, Bjerkvig R, Tiekotter K, Antel J, Matte R. 1994a. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol 56:732-740.
85. Ulvestad E, Williams K, Bo L, Trapp B, Antel J, Mork S. 1994b. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology 82:535-541.
86. Ulvestad E, Williams K, Matre R, Nyland H, Olivier A, Antel J. 1994c. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol 53:27-36.
87. Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN, Bluestone JA, Miller SD. 1998. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev 164:63-72.
88. Vanguri P, Koski CL, Silverman B, Shin ML. 1982. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. Proc Natl Acad Sci USA 79: 3290-3294.
89. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166:249-255.
90. Wang MJ, Jeng KC, Kuo JS, Chen HL, Huang HY, Chen WF, Lin SZ. 2004. c-Jun N-terminal kinase and, to a lesser extent, p38 mitogen-activated protein kinase regulate inducible nitric oxide synthase expression in hyaluronan fragments-stimulated BV-2 microglia. J Neuroimmunol 146:50-62.
91. Wierzba-Bobrowicz T, Schmidt-Sidor B, Gwiazda E, Lechowicz W, Kosno-Kruszewska E. 2000. Major histocompatibility complex class II expression in the frontal and temporal lobes in the human fetus during development. Folia Neuropathol 38:73-77.
92. Williams K, Alvarez X, Lackner AA. 2001. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36:156-164.
93. Williams K, Bar-Or A, Ulvestad E, Olivier A, Antel JP, Yong VW. 1992. Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol 51:538-549.
94. Williams K, Dooley N, Ulvestad E, Becher B, Antel JP. 1996. IL-10 production by adult human derived microglial cells. Neurochem Int 29:55-64.
95. Williams K, Ulvestad E, Antel J. 1994a. Immune regulatory and effector properties of human adult microglia studies in vitro and in situ. Adv Neuroimmunol 4:273-281.
96. Williams K Jr, Ulvestad E, Cragg L, Blain M, Antel JP. 1993. Induction of primary T cell responses by human glial cells. J Neurosci Res 36: 382-390.
97. Williams K, Ulvestad E, Waage A, Antel JP, McLaurin J. 1994b. Activation of adult human derived microglia by myelin phagocytosis in vitro. J Neurosci Res 38:433-443.
98. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 182:1985-1996.
99. Wolfson C, Talbot P. 2002. Bacterial infection as a cause of multiple sclerosis. Lancet 360:352-353.
100. Yong VW, Chabot S, Stuve O, Williams G. 1998. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 51:682-689.
101. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. 2004. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-1526.
102. Zhang G, Ghosh S. 2001. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107:13-19.
103. Zhao ML, Liu JS, He D, Dickson DW, Lee SC. 1998. Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain. Brain Res 813:402-405.